
Sign up to save your podcasts
Or
Former Congressman Waxman discusses the passage of the seminal Hatch-Waxman Act, recent proposals to improve the balance between rights of brand name pharmaceutical and generic companies, and his 40-year career in Congress.
5
4949 ratings
Former Congressman Waxman discusses the passage of the seminal Hatch-Waxman Act, recent proposals to improve the balance between rights of brand name pharmaceutical and generic companies, and his 40-year career in Congress.
6,069 Listeners
14,157 Listeners
24 Listeners
1,782 Listeners
9,067 Listeners
935 Listeners
55,956 Listeners
5,284 Listeners
5,417 Listeners
2 Listeners
2,207 Listeners
3,276 Listeners
450 Listeners
977 Listeners
5 Listeners